Royce & Associates’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-36,428
| Closed | -$1.09M | – | 1263 |
|
|
2017
Q2 | $1.09M | Sell |
36,428
-22,238
| -38% | -$667K | 0.01% | 952 |
|
|
2017
Q1 | $1.75M | Hold |
58,666
| – | – | 0.01% | 891 |
|
|
2016
Q4 | $2.03M | Sell |
58,666
-29,160
| -33% | -$1.01M | 0.01% | 821 |
|
|
2016
Q3 | $5.81M | Sell |
87,826
-67,994
| -44% | -$4.49M | 0.04% | 543 |
|
|
2016
Q2 | $8.84M | Sell |
155,820
-4,000
| -3% | -$227K | 0.06% | 416 |
|
|
2016
Q1 | $9.32M | Buy |
159,820
+19,300
| +14% | +$1.13M | 0.06% | 412 |
|
|
2015
Q4 | $8.26M | Buy |
140,520
+21,300
| +18% | +$1.25M | 0.05% | 467 |
|
|
2015
Q3 | $6.82M | Buy |
119,220
+15,360
| +15% | +$879K | 0.04% | 565 |
|
|
2015
Q2 | $9.38M | Buy |
103,860
+29,660
| +40% | +$2.68M | 0.04% | 560 |
|
|
2015
Q1 | $7.14M | Buy |
74,200
+1,042
| +1% | +$100K | 0.03% | 673 |
|
|
2014
Q4 | $6.41M | Buy |
73,158
+20,158
| +38% | +$1.76M | 0.02% | 727 |
|
|
2014
Q3 | $4.84M | Hold |
53,000
| – | – | 0.02% | 821 |
|
|
2014
Q2 | $6.1M | Sell |
53,000
-2,785
| -5% | -$321K | 0.02% | 807 |
|
|
2014
Q1 | $6.76M | Sell |
55,785
-8,615
| -13% | -$1.04M | 0.02% | 799 |
|
|
2013
Q4 | $8.1M | Sell |
64,400
-4,000
| -6% | -$503K | 0.02% | 745 |
|
|
2013
Q3 | $7.44M | Buy |
68,400
+1,240
| +2% | +$135K | 0.02% | 750 |
|
|
2013
Q2 | $5.66M | Buy |
+67,160
| New | +$5.66M | 0.02% | 804 |
|